Qingfeng Lin

464 total citations
20 papers, 377 citations indexed

About

Qingfeng Lin is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Qingfeng Lin has authored 20 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Qingfeng Lin's work include Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Qingfeng Lin is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Qingfeng Lin collaborates with scholars based in China, United Kingdom and Norway. Qingfeng Lin's co-authors include Weidong Mao, Dong Shen, Feng Lin, Katrien Wijndaele, Qiong Wang, Xiangdong Lu, Shaoping Liu, Tao Liu, Ulf Ekelund and Zhili Liu and has published in prestigious journals such as PLoS ONE, Experimental Cell Research and Advanced Science.

In The Last Decade

Qingfeng Lin

20 papers receiving 374 citations

Peers

Qingfeng Lin
Qingfeng Lin
Citations per year, relative to Qingfeng Lin Qingfeng Lin (= 1×) peers Yolanda Saldaña‐Alvarez

Countries citing papers authored by Qingfeng Lin

Since Specialization
Citations

This map shows the geographic impact of Qingfeng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingfeng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingfeng Lin more than expected).

Fields of papers citing papers by Qingfeng Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingfeng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingfeng Lin. The network helps show where Qingfeng Lin may publish in the future.

Co-authorship network of co-authors of Qingfeng Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Qingfeng Lin. A scholar is included among the top collaborators of Qingfeng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingfeng Lin. Qingfeng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Chen, Zhangding Wang, Qingfeng Lin, et al.. (2025). NAT10 Promotes Gastric Cancer Liver Metastasis by Modulation of M2 Macrophage Polarization and Metastatic Tumor Cell Hepatic Adhesion. Advanced Science. 12(15). e2410263–e2410263. 9 indexed citations
2.
Lin, Qingfeng, et al.. (2024). Identification and immunological characteristics of anoikis-associated molecular clusters in lung adenocarcinoma. Experimental Cell Research. 438(1). 114037–114037. 2 indexed citations
3.
Chen, Jin, et al.. (2022). The correlation between multimodal radiomics and pathology about thermal ablation lesion of rabbit lung VX2 tumor. Frontiers in Oncology. 12. 941752–941752. 1 indexed citations
4.
Lin, Qingfeng, Jie Chen, Zhili Liu, et al.. (2022). Differential expression of Tim3 protein in colorectal cancer associated with MSI and Braf mutation.. PubMed. 37(5). 441–448. 3 indexed citations
5.
Lin, Qingfeng, et al.. (2021). Efficacy of afatinib in a patient with rare EGFR (G724S/R776H) mutations and amplification in lung adenocarcinoma: A case report. World Journal of Clinical Cases. 9(6). 1329–1335. 4 indexed citations
6.
Li, Suqing, Weihong Shi, Qingfeng Lin, et al.. (2019). Cyclin A1 is associated with poor prognosis in oesophageal squamous cell carcinoma. Oncology Letters. 18(1). 706–712. 7 indexed citations
7.
Zhao, Jiyi, Yi Gao, Wenkai Xia, et al.. (2018). TAB3 promotes human esophageal squamous cell carcinoma proliferation and invasion via the NF‑κB pathway. Oncology Reports. 40(5). 2876–2885. 8 indexed citations
8.
Su, Jun, Erbao Zhang, Liang Han, et al.. (2017). Long noncoding RNA BLACAT1 indicates a poor prognosis of colorectal cancer and affects cell proliferation by epigenetically silencing of p15. Cell Death and Disease. 8(3). e2665–e2665. 84 indexed citations
9.
Lin, Qingfeng, Weidong Mao, Qingquan Wu, et al.. (2017). Downregulation of KLK13 promotes the invasiveness and metastasis of oesophageal squamous cell carcinoma. Biomedicine & Pharmacotherapy. 96. 1008–1015. 3 indexed citations
10.
Pan, Fan, Yingchao Wang, Xin Zhang, et al.. (2017). Long-term adefovir therapy may induce Fanconi syndrome: A report of four cases. Experimental and Therapeutic Medicine. 14(1). 424–430. 1 indexed citations
11.
Mao, Weidong, et al.. (2016). Clinical implication of long noncoding <em>RNA 91H</em> expression profile in osteosarcoma patients. OncoTargets and Therapy. Volume 9. 4645–4652. 21 indexed citations
12.
Xia, Wenkai, Qingfeng Lin, Dong Shen, et al.. (2016). Prognostic significance of lymphocyte‐to‐monocyte ratio in diffuse large B‐cell lymphoma: a systematic review and meta‐analysis. FEBS Open Bio. 6(6). 558–565. 12 indexed citations
13.
Feng, Lin, Ye Li, Shuai Yan, et al.. (2015). MicroRNA-181a Inhibits Tumor Proliferation, Invasiveness, and Metastasis and Is Downregulated in Gastric Cancer. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 22(2). 75–84. 18 indexed citations
14.
Shen, Dong, Weidong Mao, Tao Liu, et al.. (2014). Sedentary Behavior and Incident Cancer: A Meta-Analysis of Prospective Studies. PLoS ONE. 9(8). e105709–e105709. 100 indexed citations
15.
Lin, Qingfeng, et al.. (2014). [Hypophosphatemic osteomalacia and renal Fanconi syndrome induced by adefovir in a patient with chronic hepatitis B].. PubMed. 22(10). 779–80. 2 indexed citations
16.
Wang, Weixin, Qingfeng Lin, Dong Shen, et al.. (2013). Clinicopathological significance of SLP-2 overexpression in human gallbladder cancer. Tumor Biology. 35(1). 419–423. 9 indexed citations
17.
Zhang, Dongqing, et al.. (2013). [Risk factors of hepatorenal syndrome in patients with acute on chronic liver failure].. PubMed. 21(10). 743–6. 2 indexed citations
18.
Lin, Qingfeng, Weidong Mao, Yongqian Shu, et al.. (2011). A cluster of specified microRNAs in peripheral blood as biomarkers for metastatic non-small-cell lung cancer by stem-loop RT-PCR. Journal of Cancer Research and Clinical Oncology. 138(1). 85–93. 67 indexed citations
19.
Wang, Rongsheng, Lingxiang Liu, Yanhong Gu, et al.. (2009). The effect of endostatin and gemcitabine combined with HIFU on the animal xenograft model of human pancreatic cancer. Biomedicine & Pharmacotherapy. 64(5). 309–312. 23 indexed citations
20.
Lin, Qingfeng, et al.. (2009). The effect of HIFU combined with endostar and gemcitabine on the animal xenograft model of human pancreatic cancer. Biomedicine & Pharmacotherapy. 63(5). 325–325. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026